Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07558655Active Not Recruiting

The Glean Registry

Role: lead

NCT05694793Not ApplicableRecruiting

Trial for Reliability of Urodynamics SysTem

Role: lead

NCT07485205Not ApplicableRecruiting

Establishing Normative Urodynamics Parameters for the Glean Urodynamics System in Healthy Adults

Role: lead

NCT07425015Not ApplicableRecruiting

Ambulatory Long Length URodynamics Evaluation

Role: lead

NCT05959655Not ApplicableCompleted

Modern Urodynamics System Efficacy (MUSE) Study

Role: lead

All 5 trials loaded